Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Carisma Therapeutics Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CARM: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders53158+6
Shares9.58M40.4K9.37M−172.8K (−1.8%)
Value$84.0M$354.6K$39.6M−$44.0M (−52.6%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Carisma Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CARM in Q3 2023
InstitutionSharesValue% of portfolio
Arrowstreet Capital, Limited Partnership179,583$760.0K0.00%
American Century Companies Inc15,781$66.8K0.00%
SG Americas Securities, LLC13,653$58.0K0.00%
Deutsche Bank AG12,267$51.9K0.00%
Hussman Strategic Advisors, Inc.5,250$22.2K0.00%
Allspring Global Investments Holdings, LLC1,204$5.09K0.00%
Peoples Bank250$1.06K0.00%
Northwestern Mutual Wealth Management Co25$1060.00%
CWM, LLC10$00.00%

Sold out (3)

Institutions that held Carisma Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CARM in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Connor, Clark & Lunn Investment Management Ltd.14,796$129.8K
CSS LLC10,485$92.0K
Susquehanna International Group, LLP10,259$90.0K

Not filed for Q3 2023 yet (1)

Institutions that held Carisma Therapeutics Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CARM in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
EA Series Trust40,434$354.6K